Stocks making the biggest moves midday: CVS, Credit Suisse, AMD, Lyft and more

Check retired the companies making headlines successful midday trading Friday.

Ambac Financial Group – Shares of the municipal enslaved insurer changeable up 13.2% connected quality of settlements with Bank of America that would bring Ambac $1.84 billion. The settlements travel retired of lawsuits related to the enslaved security policies Ambac utilized for Bank of America anterior to the 2008 fiscal crisis. Bank of America was down astir 2.4%.

Levi Strauss – Levi's dropped 9.3% aft cutting its full-year income and nett outlook Thursday, arsenic the covering shaper cited issues stemming from the proviso concatenation and the stronger U.S. dollar.

DraftKings – Shares of DraftKings roseate 1% connected a Bloomberg study that the online sports betting institution is adjacent to a concern woody with ESPN.

Lyft – The rideshare institution slid 7.9% aft RBC downgraded the banal to assemblage execute from outperform. RBC said rival Uber, which was down astir 4.5%, had "structural advantages."

CVS Health – Shares of CVS dropped 11.3% pursuing a study that the wellness attraction elephantine is successful "exclusive talks" to bargain Cano Health. The institution had already been falling aft the Centers for Medicare and Medicaid Services downgraded 1 of its Aetna Medicare Advantage plans successful its yearly ratings. Shares of Cano gained 9%.

Tesla, Twitter – The 2 businesses continued to determination pursuing a week of quality connected Elon Musk reviving his high-profile plans to acquisition Twitter. Tesla fell 6.1%, portion Twitter mislaid 0.2%. On Thursday, a justice said Musk needs to implicit his acquisition by Oct. 28 to debar a trial.

Credit Suisse – The European slope was up 10.8% aft offering to buy backmost $3 cardinal successful indebtedness securities Friday and merchantability a celebrated edifice it owns. It marks different time of tumult for shares of the banal — which deed an all-time debased earlier successful the week — arsenic marketplace observers questioned the bank's health.

DexCom – Shares of the shaper of glucose monitoring devices jumped 9% aft the Centers for Medicare and Medicaid Services updated a section sum determination related to specified devices. The determination could boost the bottommost enactment for DexCom, a cardinal subordinate successful the continuous glucose monitoring space.

Apple – The tech elephantine was down 3.5% contempt Morgan Stanley reiterating the banal arsenic overweight, noting elevated pb times for the iPhone. People pursuing the institution person raised interest implicit the show of the caller enactment of iPhones compared to erstwhile rollouts arsenic Apple yanked plans to summation production.

Meta – The Facebook proprietor besides slid 3% contempt being reiterated arsenic a bargain by Citi, which noted an appealing risk/reward outlook arsenic Reels gross increases and caller advertisement formats travel into play.

Cannabis companies – Shares of cannabis companies were each down, aft initially soaring connected quality that President Joe Biden wants a reappraisal of however marijuana is classified nether national law. Biden besides announced he'll pardon thousands convicted of marijuana possession. Tilray Brands, which reported a larger-than-expected quarterly nonaccomplishment connected Friday, was down 16%. Canopy Growth plunged much than 22%, Aurora Cannabis fell 11% and Cronos Group mislaid 10%.

Advanced Micro Devices – Shares of Advanced Micro Devices plummeted 11.2% aft the semiconductor institution issued disappointing preliminary results for the 3rd 4th and said it expects revenue to autumn abbreviated of its erstwhile $6.7 cardinal dollar forecast. AMD blamed the shortfall connected weakening PC request and proviso concatenation constraints. Shares of different spot companies including Intel and Nvidia fell connected the news.

Unity Software – Shares of Unity, which is known for its bundle for three-dimensional design, dropped 8.3%. It contrasts with Needham earlier Friday initiating the banal arsenic a bargain with an upside of 39%.

Provention – Shares of the biopharmaceutical institution leaped 11.8%, continuing to rally connected quality Thursday of plans to motorboat a cause campaigner for benignant 1 diabetes.

— CNBC's Samantha Subin, Michelle Fox, Carmen Reinicke, Tanaya Macheel and Yun Li contributed reporting.